| Name | Tadnersen |
|---|
| Description | Tadnersen (BIIB078), an antisense oligonucleotide (ASO), selectively targets C9ORF72 transcript variants 1 and 3 that carry the expansion[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Tadnersen (BIIB078) is an RNAse H oligomer that selectively inhibits mutant C9ORF72 transcripts. Tadnersen is used for the research of Amyotrophic Lateral Sclerosis (ALS)[2]. |
| References |
| No Any Chemical & Physical Properties |